Clinical Enrollment partners with biopharma teams to take full ownership of clinical trial patient recruitment, managing everything from patient identification through screening and site follow-through. The company operates on a success-based pricing model, meaning they only get paid when enrollment milestones are met, aligning their incentives with sponsor goals. Their social targeting strategy spans multiple platforms to reach relevant patient communities, delivering an average of 4.4x faster recruitment and an 18% reduction in screen fail rates.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical trials frequently miss enrollment targets or experience significant delays, costing sponsors over $330,000 per day in cash burn. Traditional recruitment methods often rely on limited site-based outreach and generic advertising, which fails to reach sufficiently large or well-qualified patient populations, leading to stalled trials and substantial financial losses.
Solution
Clinical Enrollment provides a comprehensive patient recruitment service that takes full ownership of the enrollment process, from patient identification through screening and site follow-through. The company uses a finely-honed social targeting strategy across multiple platforms to tap directly into relevant, high-quality patient communities, identifying the right messaging and mass coverage needed to reach enrollment goals. Their double-screening process ensures sites receive the exact medical information they need, while maintaining a responsive relationship that adapts to site capacity and staffing constraints. With a success-based pricing model, Clinical Enrollment assumes all financial risk, only getting paid when mutually agreed-upon enrollment metrics are achieved.
Target Audience
Primary customers are biopharma sponsors and clinical research organizations running interventional clinical trials who need to accelerate patient enrollment, reduce screen fail rates, or rescue trials where recruitment has stalled.
Features
- Success-based pricing model where payment is contingent on achieving mutually agreed-upon enrollment metrics, eliminating financial risk for sponsors
- Social targeting strategy spanning multiple platforms, with a focus on reaching relevant patient communities through tailored messaging and mass coverage
- Double-screening process that provides sites with the precise medical information needed to make enrollment decisions
- Adaptive referral volume management that scales back during site staffing shortages to prevent overwhelming research staff
- Proven expertise across therapeutic areas including oncology, neurodegenerative conditions, dermatology, and ophthalmology
- Average results include $19.2M in sponsor savings, 57-day faster enrollment closure, 4.4x increase in recruitment speed, and 18% decrease in screen fail rates